• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15922 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to the final report A09-02 (benefit assessment of prasugrel)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for defined speech and language development disorders in children: Appraisal of the KiSS.2 study]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of HPV test in primary screening for cervical cancer]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Boceprevir - Benefit assessment according to 35a Social Code Book V (dossier assessment)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pirfenidone - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal for the DMP module on heart failure and extraction of new, relevant recommendations]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Stem cell transplantation for multiple myeloma: assessment of the BMT CTN 0102 study]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Linagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Abiraterone acetate - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2011 National Institute for Health and Care Excellence (NICE) Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. NICE technology appraisal guidance 223
2011 National Institute for Health and Care Excellence (NICE) Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs. NICE technology appraisal guidance 225
2011 National Institute for Health and Care Excellence (NICE) Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma. NICE technology appraisal guidance 226
2011 National Institute for Health and Care Excellence (NICE) Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer. NICE technology appraisal guidance 227
2011 National Institute for Health and Care Excellence (NICE) Bortezomib and thalidomide for the first-line treatment of multiple myeloma. NICE technology appraisal guidance 228
2011 National Institute for Health and Care Excellence (NICE) Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion. NICE technology appraisal guidance 229
2011 National Institute for Health and Care Excellence (NICE) Agomelatine for the treatment of major depressive episodes (terminated appraisal). NICE technology appraisal guidance 231
2011 National Institute for Health and Care Excellence (NICE) Mifamurtide for the treatment of osteosarcoma. NICE technology appraisal guidance 235
2011 National Institute for Health and Care Excellence (NICE) Ticagrelor for the treatment of acute coronary syndromes. NICE technology appraisal guidance 236
2011 National Institute for Health and Care Excellence (NICE) Tocilizumab for the treatment of systemic juvenile idiopathic arthritis. NICE technology appraisal guidance 238
2011 National Institute for Health and Care Excellence (NICE) Fulvestrant for the treatment of locally advanced or metastatic breast cancer. NICE technology appraisal guidance 239
2011 National Institute for Health and Care Excellence (NICE) Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal). NICE technology appraisal guidance 240
2011 National Institute for Health and Care Excellence (NICE) Epiretinal brachytherapy for wet age-related macular degeneration. NICE interventional procedures guidance 415
2011 National Institute for Health and Care Excellence (NICE) Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants. NICE interventional procedures guidance 412
2011 National Institute for Health and Care Excellence (NICE) Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids. NICE interventional procedures guidance 413
2011 National Institute for Health and Care Excellence (NICE) Single-port laparoscopic nephrectomy. NICE interventional procedures guidance 414
2011 National Institute for Health and Care Excellence (NICE) Arthroscopic femoro–acetabular surgery for hip impingement syndrome. NICE interventional procedures guidance 408
2011 National Institute for Health and Care Excellence (NICE) Minimally invasive oesophagectomy. NICE interventional procedures guidance 407
2011 National Institute for Health and Care Excellence (NICE) Laparoscopic cryotherapy for renal cancer. NICE interventional procedures guidance 405
2011 National Institute for Health and Care Excellence (NICE) Percutaneous cryotherapy for renal cancer. NICE interventional procedures guidance 402
2011 National Institute for Health and Care Excellence (NICE) Open femoro–acetabular surgery for hip impingement syndrome. NICE interventional procedures guidance 403
2011 National Institute for Health and Care Excellence (NICE) Endoscopic radical inguinal lymphadenectomy. NICE interventional procedures guidance 398
2011 National Institute for Health and Care Excellence (NICE) Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism. NICE interventional procedures guidance 400
2011 National Institute for Health and Care Excellence (NICE) Endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence. NICE interventional procedures guidance 393
2011 National Institute for Health and Care Excellence (NICE) Percutaneous tibial nerve stimulation for faecal incontinence. NICE interventional procedures guidance 395
2011 National Institute for Health and Care Excellence (NICE) Trabeculotomy ab interno for open angle glaucoma. NICE interventional procedures guidance 397
2011 National Institute for Health and Care Excellence (NICE) Carotid artery stent placement for symptomatic extracranial carotid stenosis. NICE interventional procedures guidance 389
2011 National Institute for Health and Care Excellence (NICE) Endovascular stent-grafting of popliteal aneurysms. NICE interventional procedures guidance 390
2011 National Institute for Health and Care Excellence (NICE) Extracorporeal membrane oxygenation for severe acute respiratory failure in adults. NICE interventional procedures guidance 391
2011 National Institute for Health and Care Excellence (NICE) Stent insertion for bleeding oesophageal varices. NICE interventional procedures guidance 392
2011 National Institute for Health and Care Excellence (NICE) Hand allotransplantation. NICE interventional procedures guidance 383
2011 National Institute for Health and Care Excellence (NICE) Percutaneous retroperitoneal endoscopic necrosectomy. NICE interventional procedures guidance 384
2011 National Institute for Health and Care Excellence (NICE) Laser correction of refractive error following non-refractive ophthalmic surgery. NICE interventional procedures guidance 385
2011 National Institute for Health and Care Excellence (NICE) Deep brain stimulation for intractable trigeminal autonomic cephalalgias. NICE interventional procedures guidance 381
2011 National Institute for Health and Care Excellence (NICE) Deep brain stimulation for refractory chronic pain syndromes (excluding headache). NICE interventional procedures guidance 382
2011 National Institute for Health and Care Excellence (NICE) Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices. NICE interventional procedures guidance 380
2011 National Institute for Health and Care Excellence (NICE) Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome. NICE interventional procedures guidance 376
2011 National Institute for Health and Care Excellence (NICE) Off-pump coronary artery bypass grafting. NICE interventional procedures guidance 377
2011 National Institute for Health and Care Excellence (NICE) Percutaneous laser coronary angioplasty. NICE interventional procedures guidance 378
2011 National Institute for Health and Care Excellence (NICE) Thoracoscopic repair of congenital diaphragmatic hernia in neonates. NICE interventional procedures guidance 379
2011 National Institute for Health and Care Excellence (NICE) Distal iliotibial band lengthening for refractory greater trochanteric pain syndrome. NICE interventional procedures guidance 375
2011 National Institute for Health and Care Excellence (NICE) MiraQ for assessing graft flow during coronary artery bypass graft surgery. NICE medical technologies guidance 8
2011 National Institute for Health and Care Excellence (NICE) moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment. NICE medical technologies guidance 2
2011 National Institute for Health and Care Excellence (NICE) Ambulight PDT for the treatment of non-melanoma skin cancer. NICE medical technologies guidance 6
2011 National Institute for Health and Care Excellence (NICE) The MIST Therapy system for the promotion of wound healing. NICE medical technologies guidance 5
2011 National Institute for Health and Care Excellence (NICE) The EOS 2D/3D imaging system. NICE diagnostics guidance 1
2011 Canary Health Service [Cost-effectiveness of gastric bypass]
2011 Canary Health Service [Cost-effectiveness of implantable automatic defibrillator in primary prevention in Spain]
2011 Canary Health Service [Systematic review of utilities or preferences for health states obtained from the Spanish population]
2011 Canary Health Service [Variations, inequalities, degree of inappropriate use and avoidable costs of imaging tests in the diagnosis and follow-up of stroke patients in the Canary Islands]
2011 Canary Health Service [Prophylaxis of postoperative endophthalmitis in lens surgery]
2011 Canary Health Service [Systematic review of utilities obtained from Spanish population with cancer, diabetes and heart problems]
2011 Canary Health Service [Cost-effectiveness of interventions to prevent and correct childhood obesity]
2011 Canary Health Service [Effectiveness and cost-effectiveness of implantable automatic defibrillators in Spain]
2011 National Institute for Health and Care Excellence (NICE) Golimumab for the treatment of psoriatic arthritis. NICE technology appraisal guidance 220
2011 National Institute for Health and Care Excellence (NICE) Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia. NICE technology appraisal guidance 218
2011 National Institute for Health and Care Excellence (NICE) Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer. NICE technology appraisal guidance 214
2011 National Institute for Health and Care Excellence (NICE) Bendamustine for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 216
2011 National Institute for Health and Care Excellence (NICE) Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years. NICE technology appraisal guidance 213
2010 NIHR Health Technology Assessment programme Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial
2010 NIHR Health Technology Assessment programme A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial
2010 NIHR Health Technology Assessment programme Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR)
2010 NIHR Health Technology Assessment programme NESTAC: North of England Study of Tonsillectomy and Adeno-tonsillectomy in children
2010 NIHR Health Technology Assessment programme Multi-centre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women scheduled for wide local excision (COMICE)
2010 NIHR Health Technology Assessment programme A randomised 2x2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up
2010 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Rehabilitation after breast cancer, colorectal cancer and prostate cancer – a health technology assessment]
2010 NIHR Health Technology Assessment programme A randomised controlled equivalence trial to determine the effectiveness and cost utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX)
2010 NIHR Health Technology Assessment programme Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial
2010 NIHR Health Technology Assessment programme BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A
2010 NIHR Health Technology Assessment programme A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial
2010 NIHR Health Technology Assessment programme A multicentred randomised controlled trial of a primary-care based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial
2010 NIHR Health Technology Assessment programme LIFELAX - diet and LIFEstyle versus LAXatives in the management of chronic constipation in older people: randomised controlled trial
2010 NIHR Health Technology Assessment programme Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Continuous flow registration for early detection of hepatic artery thrombosis after liver transplantation. Innovative technology reducing retransplantation rate?]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of care for patients with type 2 diabetes, an evaluation of an innovative shared diabetes care model ("Ketenzorg model")]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [E-health in caring for patients with atopic dermatitis. An economic evaluation comparing usual care with Internet-guided monitoring and self-management training by a nurse practitioner]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Transmural nutritional support]
2010 NIHR Health Technology Assessment programme Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer
2010 Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated factor VII for prevention of bleeding unrelated to hemophilia: clinical and economic systematic review
2010 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Dental indications for standardised procedures of instrumental functional analysis under consideration of health economic aspects]
2010 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The impact of microsurgery, stereotactic radiosurgery and radiotherapy in the treatment of meningiomas depending on different localizations]
2010 Institute of Health Economics (IHE) Routine preoperative electrocardiogram and chest x-ray prior to elective surgery in Alberta, Canada
2010 Belgian Health Care Knowledge Centre (KCE) Organisation and financing of chronic dialysis in Belgium
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Induction of labour versus expectant management in women with preterm premature rupture of membranes between 34 and 37 weeks (PPROMEXIL-study)]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Laparoscopy versus laparotomy in treatment of early stage endometrial cancer: a multi-centre cost-effectiveness study]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Reducing bilirubin-induced neurological dysfunction in premature newborns: additional use of bilirubin:albumin ratio in the treatment of hyperbilirubinemia]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [A controlled trial of geriatric liaison intervention in frail surgical oncology patients]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Triptan overuse in migraine in primary care, a proactive approach]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Effectiveness and costs of post-diagnosis treatment in dementia coordinatedby multidisciplinary memory clinics in comparison to treatment coordinated by GP's]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Proxy HRQL value measurement in Alzheimer's dementia]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Efficiency of the induction of personalised psychiatric rehabilitation through assessment of, and continuous feedback on, needs and outcomes - a catchment area observational trial]